Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination

Bipin Chaurasia; Vishal Chavda; Bingwei Lu; Kanwaljeet Garg; Nicola Montemurro

doi:10.1016/j.bbih.2022.100463

Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination

Brain Behav Immun Health. 2022 Jul:22:100463. doi: 10.1016/j.bbih.2022.100463. Epub 2022 Apr 23.

Authors

Bipin Chaurasia¹, Vishal Chavda², Bingwei Lu², Kanwaljeet Garg³, Nicola Montemurro⁴

Affiliations

¹ Department of Neurosurgery, Bhawani Hospital and Research Centre, Birgunj, Nepal.
² Department of Pathology, Stanford School of Medicine, Stanford University Medical Center, USA.
³ Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.
⁴ Department of Neurosurgery, Azienda Ospedaliera Universitaria Pisana (AOUP), University of Pisa, Pisa, Italy.

Abstract

Vaccination is an essential public health strategy to control the 2019 Coronavirus (COVID-19) pandemic. While the benefits of the COVID-19 vaccines far outweigh the risks, side effects continue to be reported in the literature. We report a 65-year-old man who developed cognitive deficits and memory impairments following his first dose of Oxford AstraZeneca vaccine (Covishield). The onset of acute cognitive deficits and memory impairments could be another complication to COVID-19 vaccination that physicians and neurologists need to be warned to. Monitoring the safety of COVID-19 vaccines and describing side effects associated with them is essential to improve safety profiles and enhance public trust.

Keywords: COVID-19; Cognitive deficits; Coronavirus; SARS-CoV; Vaccination.